Report Categories
View AllRecent Articles
View All
How Dynamix ETHMW differentiation drives financial results ETHMW Latest Quarter Earnings Dynamix reports no available EPS and revenue data
RCUS Arcus Biosciences posts narrower than expected Q4 2025 losses lifting mild positive investor sentiment
VRAX Virax outlines new infectious disease testing rollout plans to drive upcoming fiscal year growth
AUPH Aurinia beats Q4 2025 EPS estimates by 176 percent yet shares dip 1 percent in todays session